SHELTON CAPITAL MANAGEMENT - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 239 filers reported holding NEKTAR THERAPEUTICS in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
SHELTON CAPITAL MANAGEMENT ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2023$8,339
-68.9%
11,8640.0%0.00%
-100.0%
Q4 2022$26,813
-29.4%
11,8640.0%0.00%
+50.0%
Q3 2022$38,000
-15.6%
11,8640.0%0.00%0.0%
Q2 2022$45,000
-29.7%
11,8640.0%0.00%0.0%
Q1 2022$64,000
-53.6%
11,864
+15.7%
0.00%
-60.0%
Q4 2021$138,000
-25.0%
10,2500.0%0.01%
-28.6%
Q3 2021$184,000
+4.5%
10,2500.0%0.01%0.0%
Q2 2021$176,000
-14.1%
10,2500.0%0.01%0.0%
Q1 2021$205,000
+17.8%
10,2500.0%0.01%
-12.5%
Q4 2020$174,000
+2.4%
10,2500.0%0.01%
+14.3%
Q3 2020$170,000
-28.3%
10,2500.0%0.01%
-46.2%
Q2 2020$237,000
+23.4%
10,250
-4.5%
0.01%
-7.1%
Q1 2020$192,000
-23.2%
10,730
-7.4%
0.01%0.0%
Q4 2019$250,000
-70.0%
11,587
-17.0%
0.01%
-73.6%
Q4 2017$833,000
+148.7%
13,9520.0%0.05%
+130.4%
Q3 2017$335,000
+12.0%
13,952
-8.7%
0.02%
+9.5%
Q2 2017$299,000
-6.3%
15,283
+12.5%
0.02%
-4.5%
Q1 2017$319,000
+132.8%
13,587
+21.4%
0.02%
+120.0%
Q4 2016$137,000
-28.6%
11,1950.0%0.01%
-37.5%
Q3 2016$192,000
+20.8%
11,1950.0%0.02%
+14.3%
Q2 2016$159,000
+3.2%
11,1950.0%0.01%0.0%
Q1 2016$154,000
-9.9%
11,195
+10.2%
0.01%
-17.6%
Q4 2015$171,000
+54.1%
10,1600.0%0.02%
+41.7%
Q3 2015$111,00010,1600.01%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders